One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
A universal low-serum medium especially developed for efficient culture of adherent cells
LS902 low-serum medium for adherent cells, independently developed by Shanghai BioEngine Sci-Tech Co., Ltd., supports the proliferation of adherent cells with high density after adding 3-5% serum, suitable for the low-serum culture of Vero, 293, ST, Marc145, PK15 and other adherent cells. LS902 is developed based on BioEngine's artificial intelligence platform with limited chemical composition to meet the growing needs of different cells and promote cell proliferation and viral replication. It does not contain exclusive ingredients in the raw material formulation, minimizing the influence of the raw material supply chain on medium production and supply. The addition of low levels of serum can reduce serum costs while facilitating downstream purification. Different packaging specifications are available on the process requirements of different customers, and the cold chain transportation in the whole process ensures the reliable quality of packaging products.
Features
3-5% serum addition
No adaptation required, supporting continuous passage
Generally suitable for common adherent cell lines
Used as both cell growth solution and maintenance solution
Advantages
3-5% serum addition at a controlled cost
Optional powder media for use in large-scale manufacturing with easy preparation procedures;
Powder media capable of a single batch size of 150,000 L;
Excellent inter-batch consistency (CPK*>1.33);
Full traceability by EU-certified ISO13485:2016 Quality Management System.
*CPK: Process Capability Index. CPK>1.33 indicates good process control and small inter-batch difference of products.
Audited Supplier
Pharma Sources Insight January 2025
